Felis ISSN 2398-2950

Amikacin

Contributor(s): Vetstream Ltd

Introduction

Name

  • Amikacin.

Class of drug

  • Aminoglycoside antibiotic.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Gram-negative infections, including Pseudomonas spp.
  • Ineffective against anaerobes.
  • Some efficacy against Staphylococcus spp.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmacokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

  • Avoid the concurrent use of other nephrotoxic, ototoxic or neurotoxic agents (eg amphotericin B, cisplatin, furosemide, methoxyflurane, NSAIDs).
  • Aminoglycosides may be inactivated by beta-lactam antibiotics (eg penicillins, cephalosporins or heparin) when mixed in vitro. This may present a problem in vivo in patients who have substantially diminished renal function.
  • The effect of non-depolarizing muscle relaxants (eg atracurium, pancuronium, tubocuramine, vecuronium) may be enhanced by aminoglycosides.
  • Synergism may occur when aminoglycosides are used with penicillins or cephalosporins (Streptococcus faecalis) or with ticarcillin Ticarcillin (Pseudomonas aeruginosa).

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

Other sources of information

  • Based on Small Animal Formulary. Tennant, Bryn (1999) 3rd edn. Cheltenham: BSAVA ISBN: 0 905214 44 7.

ADDED